[PDF] Top 20 The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma
Has 10000 "The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma" found on our website. Below are the top 20 most common "The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma".
The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma
... Although the prognostic role of BRAF V600E mutation in papillary thyroid carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes ... See full document
7
Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
... [14-17]. The association of incretin-based therapy with thyroid cancer originates from preclinical data showing the elevation of calci- tonin and occurrence of hyperplasia and tumors ... See full document
9
Prevalence of BRAF Mutation in Papillary Thyroid Cancer
... all thyroid malignancies ...common, and a minority of patients with recurrent disease ...higher risk of recurrence, or when a more aggressive disease is expected need to be identified for ... See full document
7
Intermediate-risk thyroid carcinoma: indicators of a poor prognosis
... intermediate- risk DTC according to the 2015 ATA risk stratification guidelines were ...of the total patients were female, and 86.8% had papillary thyroid ...of ... See full document
8
Aggressive papillary thyroid carcinoma in a child with type 2 congenital generalized lipodystrophy
... Thyroid carcinoma (TC) is rare in children, particularly in those aged < 10 ...neoplasms and hyperinsulinemia and insulin resistance, which are often associated with a higher ... See full document
5
Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter
... (25,30,33) and Greece (17). Because Italy and Greece have no nuclear plants, we tend to exclude that our rate was influenced by the relative vicinity of our medical center and residence of ... See full document
10
Accuracy of sentinel lymph node mapping in detecting occult neck metastasis in papillary thyroid carcinoma
... metastases in various series (2), confirmed in the present series as ...controversy, the prognostic value of lymph node metastases was revealed in some recent studies, and it has ... See full document
7
The pathogenic role of mTOR pathway in papillary thyroid carcinoma and its impact on sodium iodide symporter (NIS) expression
... reviewed in the context of a disease – cancer – that can be (too) simplistically described as a ‘successful, invasive clone of our own ...a thyroid cancer patient’s outcome beyond the ... See full document
189
Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
... abstracted the relevant data from the included articles in accordance with the pre- pared standardized ...or papillary thyroid microcarcinoma (PTMC), case number, surgery ... See full document
17
Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series
... clinical and pathological data of the 43 selected PTC patients are summarized in Table ...2. The mean age at diagnosis was 37 years, ranging from 12 to 78 ...(88.4% and 11.6% for ... See full document
10
The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes.
... including papillary microcarcinoma (PTMC, tumor size 1 cm), is the most common type of differentiated thyroid cancer and spreads predominantly via the lymphatics to the local ... See full document
12
Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status
... to thyroid hormone (RTH) is a rare autosomal dominant hereditary ...Here in, we report two patients with RTH in whom differentiated thyroid cancer was ...clinic and their laboratory ... See full document
3
Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules
... mutations in 45 fine-needle aspiration (FNA) specimens obtained from thyroid nodules followed by postoperatively confirmation of papillary thyroid cancer (PTC) diagnosis, examining their ... See full document
6
Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma
... than in patients with PTC alone. In a large retrospective study, 19 ...mortality and a 95% relapse-free 10 year survival rate were reported in patients with chronic thyroiditis compared to 5% ... See full document
7
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America
... to the recurrent laryngeal nerve or trachea, and/or (iii) US regional lymph-node metastasis or clinical distant ...as the presence of i) a tumor larger than ≥ 3 mm, ii) novel appearance of lymph-node ... See full document
8
Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy
... ng/mL, and elevated antithyroglobulin antibodies 8---12 months after ablation were ...selected. The patients were divided into two groups: Group A, with chronic lymphocytic thyroiditis on histology; Group ... See full document
5
The genetics of Papillary Microcarcinomas of the thyroid
... (HRAS) and Kirsten Rat Sarcoma Viral Oncogene Homolog ...role in the transduction of signals from tyrosine kinase and G protein-coupled receptors to effectors of the MAPK and ... See full document
71
Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
... tients (nonaggressive histology; pT1b-3, cN0pNx, M0) with slightly elevated Tg after thyroidectomy (> 1 ng/mL, but ≤ 5 ng/mL after levothyroxine withdrawal or ≤ 2 ng/mL after recombinant human TSH). Results: ... See full document
4
Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections
... included in the TI-RADS score, mainly for reasons of ...used in expert practice to refine the risk ...to the capsule, capsular bulging, or an exclusively solid composition ... See full document
14
miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
... characterize the effect of miR-26a on cell proliferation we performed overexpression studies using a miR-26a mimic and inhibition studies using miR-26a specific anti-sense oligonucleotide inhibitor ... See full document
11
temas relacionados